Myriad Genetics
MYGN
#6699
Rank
S$0.85 B
Marketcap
S$9.19
Share price
-3.27%
Change (1 day)
-58.04%
Change (1 year)

Earnings for Myriad Genetics (MYGN)

Earnings in 2025 (TTM): -S$0.54 Billion

According to Myriad Genetics's latest financial reports the company's current earnings are S$0.82 Billion. In 2024 the company made an earning of -S$0.16 Billion, an increase over its 2023 earnings that were of -S$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Myriad Genetics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.54 Billion244.06%
2024 -S$0.16 Billion-53.49%
2023 -S$0.34 Billion88.72%
2022 -S$0.18 Billion172.08%
2021 -S$65.45 Million
2019 -S$34.09 Million-175.14%
2018 S$45.35 M-70.81%
2017 S$0.15 B22.22%
2016 S$0.12 B-38.8%
2015 S$0.20 B-6.12%
2014 S$0.22 B-41.07%
2013 S$0.37 B46.67%
2012 S$0.25 B15.84%
2011 S$0.22 B17.6%
2010 S$0.18 B-15.96%
2009 S$0.22 B
2007 -S$54.01 Million40.96%
2006 -S$38.32 Million
2003 -S$44.5 Million34.8%
2002 -S$33.01 Million89.21%
2001 -S$17.45 Million3.93%
2000 -S$16.79 Million21.76%
1999 -S$13.79 Million-25.61%
1998 -S$18.54 Million38.83%
1997 -S$13.35 Million-24.26%
1996 -S$17.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Bio-Rad Laboratories
BIO
-S$1.1 Billion 101.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
-S$1.26 Billion 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-S$45.32 Million-91.64%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.88 B-262.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.54 B-2,044.56%๐Ÿ‡บ๐Ÿ‡ธ USA